These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 31865964)

  • 21. Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease.
    Sweeney MD; Sagare AP; Zlokovic BV
    J Cereb Blood Flow Metab; 2015 Jul; 35(7):1055-68. PubMed ID: 25899298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroinflammation in Alzheimer's disease.
    Heneka MT; Carson MJ; El Khoury J; Landreth GE; Brosseron F; Feinstein DL; Jacobs AH; Wyss-Coray T; Vitorica J; Ransohoff RM; Herrup K; Frautschy SA; Finsen B; Brown GC; Verkhratsky A; Yamanaka K; Koistinaho J; Latz E; Halle A; Petzold GC; Town T; Morgan D; Shinohara ML; Perry VH; Holmes C; Bazan NG; Brooks DJ; Hunot S; Joseph B; Deigendesch N; Garaschuk O; Boddeke E; Dinarello CA; Breitner JC; Cole GM; Golenbock DT; Kummer MP
    Lancet Neurol; 2015 Apr; 14(4):388-405. PubMed ID: 25792098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation of glia from Alzheimer's mice reveals inflammation and dysfunction.
    Orre M; Kamphuis W; Osborn LM; Jansen AHP; Kooijman L; Bossers K; Hol EM
    Neurobiol Aging; 2014 Dec; 35(12):2746-2760. PubMed ID: 25002035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukins, inflammation, and mechanisms of Alzheimer's disease.
    Weisman D; Hakimian E; Ho GJ
    Vitam Horm; 2006; 74():505-30. PubMed ID: 17027528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of inflammatory processes in Alzheimer's disease.
    Broussard GJ; Mytar J; Li RC; Klapstein GJ
    Inflammopharmacology; 2012 Jun; 20(3):109-26. PubMed ID: 22535513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid associated proteins in Alzheimer's and prion disease.
    Veerhuis R; Boshuizen RS; Familian A
    Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):235-48. PubMed ID: 15975027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory response in Alzheimer's disease.
    Akiyama H
    Tohoku J Exp Med; 1994 Nov; 174(3):295-303. PubMed ID: 7539162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T Lymphocytes and Inflammatory Mediators in the Interplay between Brain and Blood in Alzheimer's Disease: Potential Pools of New Biomarkers.
    Mietelska-Porowska A; Wojda U
    J Immunol Res; 2017; 2017():4626540. PubMed ID: 28293644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamics of the Complement, Cytokine, and Chemokine Systems in the Regulation of Synaptic Function and Dysfunction Relevant to Alzheimer's Disease.
    Jiang S; Bhaskar K
    J Alzheimers Dis; 2017; 57(4):1123-1135. PubMed ID: 28372329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular and molecular influencers of neuroinflammation in Alzheimer's disease: Recent concepts & roles.
    Ghosh P; Singh R; Ganeshpurkar A; Pokle AV; Singh RB; Singh SK; Kumar A
    Neurochem Int; 2021 Dec; 151():105212. PubMed ID: 34656693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microglial activation in Alzheimer's disease.
    Schlachetzki JC; Hüll M
    Curr Alzheimer Res; 2009 Dec; 6(6):554-63. PubMed ID: 19747160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microglia and Astrocytes in Alzheimer's Disease: Implications for Therapy.
    Fakhoury M
    Curr Neuropharmacol; 2018; 16(5):508-518. PubMed ID: 28730967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroinflammation in Alzheimer's Disease: Microglia, Molecular Participants and Therapeutic Choices.
    Wang H; Shen Y; Chuang H; Chiu C; Ye Y; Zhao L
    Curr Alzheimer Res; 2019; 16(7):659-674. PubMed ID: 31580243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of complement and activated microglia in the pathogenesis of Alzheimer's disease.
    Eikelenboom P; Veerhuis R
    Neurobiol Aging; 1996; 17(5):673-80. PubMed ID: 8892339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Network-wide dysregulation of calcium homeostasis in Alzheimer's disease.
    Brawek B; Garaschuk O
    Cell Tissue Res; 2014 Aug; 357(2):427-38. PubMed ID: 24553999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammation occurs early during the Abeta deposition process in TgCRND8 mice.
    Dudal S; Krzywkowski P; Paquette J; Morissette C; Lacombe D; Tremblay P; Gervais F
    Neurobiol Aging; 2004 Aug; 25(7):861-71. PubMed ID: 15212840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological aspects and anti-amyloid strategy for Alzheimer's dementia.
    Liščić RM
    Arh Hig Rada Toksikol; 2013 Dec; 64(4):603-8. PubMed ID: 24384767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the peripheral innate immune system in the development of Alzheimer's disease.
    Le Page A; Dupuis G; Frost EH; Larbi A; Pawelec G; Witkowski JM; Fulop T
    Exp Gerontol; 2018 Jul; 107():59-66. PubMed ID: 29275160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential role of proinflammatory and antiinflammatory cytokines in Alzheimer disease pathogenesis.
    Azizi G; Mirshafiey A
    Immunopharmacol Immunotoxicol; 2012 Dec; 34(6):881-95. PubMed ID: 22970774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.